Mayo Wada

11:25 Fan-Yan Wei
RNA epitranscriptome in clinical diagnosis and beyond
11:40 Cristian Arsene
Xlinking MS for structure analysis of tau/phosphorylated tau and other proteins
11:55 Shogo Urakami
Towards Rapid and Accurate Bacterial Serotyping Using MALDI Glycotyping
12:10 Yuta Matsuoka
Breath biomarkers for monitoring lipid peroxidation and ferroptosis in vivo
12:25 Mayo Wada
Molecular composition and imaging profiles of thrombi in acute coronary syndrome

Organized by Daisuke Saigusa (Teikyo University, Japan) and Masamitsu Maekawa (Tohoku University, Japan)
Mass spectrometry has been used in chemical diagnosis of diseases due to its usefulness in measuring various biomolecules. Furthermore, it has also been put to good use in the quantitative analysis of pharmaceuticals in recent years, and is contributing to more precise medical care. In addition, many new studies of pathological molecular mechanisms have been discovered through reverse translational research based on the results of clinical research. The aim of this session is to discuss the frontier of clinical mass spectrometry in chemical diagnosis and optimization of patient treatment, as well as in reverse translational research.